Holding(s) in Company

Summary by AI BETAClose X

On September 19, 2025, Jonathan Mark Swann notified Genflow Biosciences PLC of a change in their major holdings. Swann's voting rights attached to shares increased, crossing a threshold and triggering the notification. The total number of voting rights held in the issuer is now 36,588,550, representing 8.40% of voting rights attached to shares. This is an increase from the previous notification, where Swann held 31,788,550 voting rights, representing 7.01%. The acquisition is solely through direct voting rights, with 0.00% held through financial instruments.

Disclaimer*

UK 100

Latest directors dealings